Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ilaprazole Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113354623A reveals a novel thiourea dioxide reduction route for ilaprazole intermediates, offering superior purity and cost efficiency for API manufacturing.